Submit RFI

Clinvigilant Research is Now a CDSCO-approved CRO

Press Release

Clinvigilant Research is now a CDSCO-approved CRO under G.S.R 581(E), reinforcing the commitment to regulatory excellence.
Ahmedabad, India – [Jul 9, 2025] – Clinvigilant Research, a leading Clinical Research Organization (CRO), is proud to announce its official registration and approval by the Central Drugs Standard Control Organization (CDSCO), in full compliance with the G.S.R 581(E) regulation.
This milestone underscores Clinvigilant’s steadfast commitment to regulatory excellence, ethical conduct, and the highest standards of quality in clinical research across India.
In alignment with the recent regulatory updates introduced through G.S.R 581(E), all CROs operating in India are now required to obtain formal registration with CDSCO. Clinvigilant’s timely approval highlights the organization’s proactive approach to compliance, quality management, and operational readiness.
“This approval is more than a regulatory checkbox – it’s a reflection of our core values: integrity, accountability, and scientific rigor,” said Bhumi Vyas, Director of Quality Assurance at Clinvigilant Research.. “Our team has worked diligently to meet and exceed CDSCO requirements, ensuring that our partners can move forward with confidence and trust.”
What This Means for Our Stakeholders:
  • Sponsors can rely on Clinvigilant for fully compliant, high-quality clinical operations backed by regulatory transparency.
  • Sites benefit from streamlined collaboration with a CRO dedicated to ethical standards, operational precision, and data integrity.
  • CRO Partners and industry peers can trust in a partner who prioritizes clear governance, regulatory alignment, and long-term credibility.

Clinvigilant’s CDSCO approval enables the organization to further expand its services across India while reinforcing its role as a trusted partner in clinical development.

About the Company

Clinvigilant Research is a full-service CRO dedicated to delivering high-quality, compliant, and ethically driven clinical trial solutions. With expertise across early-phase to post-marketing studies, we provide end-to-end clinical trial services to sponsors, sites, CROs & others.

Contact:
[email protected]